Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus ketorolac + lidocaine incision-site injection for post-cesarean pain
IRCT20240528061936N1Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in postoperative pain comparing Ketorolac + lidocaine with Ketorolac alone (2 arms). Primary endpoint: Pain intensity after cesarean section. Started Dec 2024; status: completed.
02
Drugs
ketorolaclidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20240528061936N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240528061936N1.